v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net loss $ (33,138,000) $ (54,017,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 24,340,000 17,375,000
Write-off of inventory and change in inventory reserve 2,891,000 2,578,000
Loss on impairment of property and equipment 0 224,000
Loss on impairment of intangible asset 0 983,000
Loss on disposal of property and equipment 3,787,000 0
Stock-based compensation 21,096,000 24,756,000
Non-cash interest expense 482,000 0
(Accretion) amortization of (discount) premium on marketable securities, net of change in accrued interest (126,000) 447,000
Non-cash lease expense 1,690,000 1,420,000
Change in allowance for expected credit losses (134,000) 152,000
Change in fair value of earn-out liability (12,435,000) (16,310,000)
Change in fair value of contingently issuable/returnable common stock liability/asset (2,614,000) (2,529,000)
Change in fair value of public warrant liability (435,000) (6,592,000)
Changes in operating assets and liabilities    
Accounts receivable (2,315,000) (6,997,000)
Inventory 9,118,000 (7,852,000)
Commission assets (933,000) (1,360,000)
Contract assets 563,000 905,000
Other assets 750,000 467,000
Prepaid expenses and other current assets (22,577,000) (964,000)
Accounts payable 3,775,000 192,000
Deferred revenue 6,868,000 12,815,000
Accrued expenses and other current liabilities 18,902,000 4,534,000
Operating lease liability (886,000) (1,080,000)
Net cash provided by (used in) operating activities 18,669,000 (30,853,000)
Cash flows from investing activities:    
Development of internal-use software (5,627,000) (6,125,000)
Purchases of property and equipment (31,367,000) (31,189,000)
Purchases of marketable securities (39,388,000) (29,367,000)
Proceeds from maturities of marketable securities 34,556,000 65,282,000
Net cash used in investing activities (41,826,000) (1,399,000)
Cash flows from financing activities:    
Proceeds from exercise of stock options 9,085,000 1,809,000
Proceeds from long-term debt 26,316,000 0
Net cash provided by financing activities 35,401,000 1,809,000
Effect of exchange rate changes on cash and cash equivalents (109,000) 21,000
Net increase (decrease) in cash and cash equivalents 12,135,000 (30,422,000)
Cash and cash equivalents    
Cash, cash equivalents, and restricted cash at beginning of period 37,015,000 67,437,000
Cash and cash equivalents at end of period 49,150,000 37,015,000
Supplemental disclosure of cash flow information    
Cash paid for interest 1,249,000 0
Supplemental disclosure of non-cash activities    
Transfer of property and equipment to inventory 4,519,000 1,345,000
Capital expenditures incurred but not yet paid 3,733,000 5,493,000
Capitalization of stock compensation 1,117,000 941,000
Operating lease liabilities arising from obtaining right-of-use assets 0 14,218,000
Conversion of contingently issuable common stock $ 3,672,000 $ 0